FIELD: medicine.
SUBSTANCE: method includes DNA separation from peripheral venous blood, analysis of genotype of locus - 322 VNTR of receptor of tumour necrosis factor of 2 type. In case if genotype 2/2-322 VNTR TNFR2 is determined -little area of myomatous knots is predicted. In case of genotypes 1/1-322 VNTR TNFR2 or 2/1-322 VNTR TNFR2, large area of myomatous knots is predicted.
EFFECT: invention application makes it possible to obtain criteria of estimating myomatous knots area, define tactics and individualize treatment basing on obtained data.
2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF CHARACTER OF UTERINE INVOLVEMENT IN MYOMATOUS NODES | 2010 |
|
RU2453850C2 |
| METHOD OF PREDICTING RISK OF DEVELOPMENT OF MYOMATOUS NODES OF LARGE SIZES IN PATIENTS WITH MYOMA | 2016 |
|
RU2616246C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING BENIGN MAMMRY DYSPLASIA IN FEMALES WITH GENITAL ENDOMETRIOSIS | 2012 |
|
RU2480763C1 |
| METHOD FOR PREDICTION OF RISK OF MULTINODULAR LESIONS ACCOMPANYING UTERINE LEIOMYOMA | 2011 |
|
RU2445625C1 |
| METHOD FOR PREDICTION OF RISK OF RECURRENCE OF SYMPTOMATIC UTERINE MYOMA AFTER SELECTIVE EMBOLIZATION OF UTERINE ARTERIES | 2021 |
|
RU2766809C1 |
| METHOD FOR PREDICTION OF FORMATION OF CHRONIC LYMPHOTIC LEUKEMIA AND ONSET DEVELOPMENT OF COMBINED COMPLICATIONS | 2011 |
|
RU2458349C1 |
| METHOD FOR SELECTING UTERINE FIBROID MEDICINE THERAPY AND COMBINATION THEREOF WITH ADENOMYOSIS IN FEMALES | 2019 |
|
RU2718267C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING AN ISCHEMIC STROKE, TAKING INTO ACCOUNT GENETIC AND MEDIUM FACTORS | 2018 |
|
RU2679635C1 |
| METHOD FOR TREATMENT OF UTERINE FIBROIDS | 2021 |
|
RU2779190C1 |
| METHOD OF DETECTING HEREDITARY PREDISPOSITION TO FAST GROWTH OF UTERINE MYOMA | 2011 |
|
RU2475740C1 |
